AI News

    J&J sees AI halving the time to generate drug development leads

    Pharma giant leverages machine learning to cut drug development lead timelines by fifty percent.

    Read the full story at Reuters Technology

    Get the day's AI news in one short email. Free.

    RT

    Reuters Technology

    Source

    Reuters Technology
    AI Analysis

    Generated insight by OnAirToday AI

    Johnson & Johnson's shift toward AI-driven drug discovery demonstrates how machine learning can drastically shrink the R&D timeline for new pharmaceutical breakthroughs. By accelerating lead generation, the industry can significantly reduce development costs and bring life-saving treatments to patients much faster than traditional methods.

    Powered by AI • Not a substitute for human analysisMore Insights →
    Read the full story at Reuters Technology →
    Share
    Filed under:AI News

    Comments

    Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.

    0/1000

    Subscribe to our Free AI Newsletter

    The Daily AI Digest, every morning. Pick your topics after you subscribe.

    Free. Unsubscribe anytime.